Business Wire

Developing Telecoms Believes China Already Has the Ability to Mass Produce 28nm Chips

11.11.2020 14:00:00 EET | Business Wire | Press release

Share

Developing Telecoms learnt from Li Ke from China Semiconductor Industry Association (CSIA) that the race of chips and the manufacturing of equipment is on to develop home grown solutions, and China already has a presence in the key areas which needed to move toward mid-to-high-end chip production. Li Ke believes that Chinese 28nm chips which can meet most of the market demand will be mass produced in one or two years.

Last year, China's IC industry generated over CNY750 billion and this is expected to reach CNY900 billion in 2020. Shared by Li Ke, IC manufacturing has made the greatest progress among the entire IC industry. China's IC production capacity last year was more than 20% of the world total, larger than any other single country. Li Ke thinks that the narrowing gap between China's IC manufacturing and the world-leading technologies is laying a solid foundation for the prominence of its IC industry, and a domestic chip manufacturing industry chain will be emerged with further advanced technologies.

Li Ke also stresses on the importance of producing 28nm chips. As mentioned by Li Ke, 28nm is the dividing line between low to mid-range and mid-to-high end IC manufacturing. Being able to produce 28nm chips means it can meet most of the demand for chips without relying on others.

Chinese government is actively backing for the chip sector. The State Council has issued the document "Several Policies for Facilitating the High-quality Development of the Integrated Circuit Industry and Software Industry in the New Era", which in part outlines new tax incentives for fabs and companies that use 28nm or smaller technologies. Other policies like "qualified integrated circuit projects or enterprises that have operated for more than 15 years shall be exempt from corporate income tax for the first ten years if they employ the 28nm process or more advanced nodes" is also included.

Developing Telecoms believes China already has the ability to mass produce 28nm chips completely on its own. After more than a decade, China has a presence at every part of the 28nm-technology industry chain and every major aspect for the strategic materials. National-level and joint enterprises projects are also advancing in key parts of China's 28nm chip industry chain such as lithography machines.

About Developing Telecoms

Developing Telecoms is the leading online news portal for telecoms in emerging markets, delivering telecommunications news and information for senior management and decision makers at network operators, governments and end users. Developing Telecoms receives 2.2 million yearly page views and gets over 760,000 yearly online visitors. Its weekly emerging markets newsletter has over 40,000 subscribers. Developing Telecoms publishes a range of special reports about telecoms in emerging markets spanning topics including 5G, IoT, Smart Cities and Last Mile Connectivity.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Alec Barton
+44 7799 417751
alec@developingtelecoms.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Jeito Capital Hits Record $1.2 Billion (€1 Billion) 1 Close for Jeito II Fund to Drive Breakthrough Therapeutic Innovation for Patients8.4.2026 09:15:00 EEST | Press release

Jeito Capital (“Jeito”), a global independent private equity fund dedicated to Biopharma, today announces the final closing of its second fund Jeito II, exceeding its target at $1.2billion (above €1billion)1,2, and marking a new major milestone for European Biopharma investment. With this new fund, Jeito has now tripled its assets under management to €1.6 billion, following the closing in 2021 of fund Jeito I at $630 million (€534 million) and reinforces its position as a leading fully independent European Biopharma investor. Jeito II will continue the strategy established with Jeito I: selectively identifying and backing 15 to 20 of the most promising clinical stage Biopharma companies, primarily in Europe, developing breakthrough therapies for severe diseases with high unmet medical needs and accelerating the development path and future market access. This fundraising allows Jeito to increase the average size of future investments in portfolio companies up to €150 million, thus drivi

Croma-Pharma Acquires Synocrom™ and Returns to Orthopaedics8.4.2026 08:00:00 EEST | Press release

Croma-Pharma is returning to the orthopaedics market with the reacquisition of Synocrom™, a hyaluronic acid product for the treatment of knee osteoarthritis. A strategic return built on proven heritage With the reacquisition of Synocrom™, Croma-Pharma is re-entering orthopaedics and further broadening its portfolio in a field with strong historical roots for the company. Until 2014, Croma was active in orthopaedics, with Synocrom™ serving as a key pillar of its offering. Synocrom™ is not a new name in the market. During the period in which Croma actively marketed the product, it became one of the leading hyaluronic acid brands in Europe and ranked among the top brands in its category. Its return therefore represents more than a portfolio expansion: it marks the continuation of a successful orthopaedic legacy and reconnects Croma with an important part of its history. The reintroduction of Synocrom™ also builds on Croma-Pharma’s long-standing expertise in the development and manufacturi

Murata Begins Mass Production of Seven Automotive MLCCs with World-leading Capacitance for Their Rated Voltage and Size, Supporting Stable Operation of In-vehicle Systems and Greater Design Flexibility8.4.2026 05:00:00 EEST | Press release

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has begun mass production of seven AEC-Q200-qualified multilayer ceramic capacitors (MLCCs) that achieve the world’s largest capacitance for a given rated voltage and size*, supporting stable operation of in-vehicle systems and greater design flexibility. Five parts in the GCM series are rated at 2.5-4 Vdc, targeting IC peripheral circuits in advanced driver assistance systems (ADAS) and autonomous driving (AD) applications. The remaining two MLCCs are rated at 25 Vdc for in-vehicle power line applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260407486750/en/ [Murata Manufacturing Co., Ltd.] Seven automotive MLCCs In recent years, as ADAS and AD technologies advance, the number and performance level of systems installed in vehicles have continued to increase. As a result, demand for higher capacitance low-voltage MLCCs used around ICs has grown to e

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)7.4.2026 23:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seven newly hired non-executive employees. The equity awards were granted on April 1, 2026 and consisted of options to purchase an aggregate of 117,445 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 55,875 shares. The options have an exercise price per share equal to $5.62, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted s

SLB OneSubsea and Subsea7 Sign Collaboration Agreement with PETRONAS Suriname7.4.2026 23:05:00 EEST | Press release

Global energy technology company SLB (NYSE: SLB) today announced the signing of a strategic collaboration agreement between PETRONAS Suriname E&P B.V. (“PETRONAS Suriname”), a subsidiary of PETRONAS and Subsea Integration Alliance, comprising SLB OneSubsea and Subsea7. This partnership aims to unlock resources in Suriname’s emerging frontier basin through innovative and cost-effective subsea solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331210557/en/ SLB OneSubsea has signed a strategic collaboration agreement between PETRONAS Suriname E&P B.V. (“PETRONAS Suriname”), a subsidiary of PETRONAS and Subsea Integration Alliance, comprising SLB OneSubsea and Subsea7. This partnership aims to unlock resources in Suriname’s emerging frontier basin through innovative and cost-effective subsea solutions. The agreement establishes a long-term framework for collaboration across the project lifecycle. This approach enables

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye